dockets: FDA-2004-D-0241
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2004-D-0241 | FDA | International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs | Nonrulemaking | 2021-09-01T01:02:15Z | 0b0000648047194f |
Links from other tables
- 6 rows from docket_id in documents